Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106279236B details a cost-effective Pd-catalyzed C-H activation route for 2-alkynyl indoles, offering significant supply chain and purity advantages for pharmaceutical manufacturing.
Novel Rh-catalyzed direct hydroxylation method offers high regioselectivity and yield for 4-alkoxy phenols, reducing steps and costs in API manufacturing.
Patent CN114478608A discloses Rh-catalyzed enantioselective silylation. Offers high ee values and novel structures for functional materials and pharma intermediates.
Patent CN110698507A details a ligand-free Pd-catalyzed method for aryl vinyl silanes, offering cost reduction in pharmaceutical intermediates manufacturing and streamlined supply chains.
Patent CN110698507A details a ligand-free Pd-catalyzed C-H alkenylation method for aryl vinyl silanes, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel Ru-catalyzed C-H activation method for benzofuran acids. Green oxidant, scalable process for API intermediates and natural products like diptoindonesin G.
Patent CN109761963B reveals green electrochemical C-H activation for 9-azacyclo-xanthenes. Discover cost-effective, scalable synthesis routes for high-purity intermediates.
Novel electrochemical C-H activation method for xanthene derivatives offering high yields and green processing for pharmaceutical supply chains.
Novel Pd-catalyzed C-H methylation method for ortho-methyl aryl formic acid derivatives. Offers mild conditions, air atmosphere, and scalable synthesis for pharmaceutical intermediates.
Novel one-pot cascade reaction for anticancer indenopyrazolopyrazolones. Efficient Ru-catalyzed route offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN109369504B details a novel Pd-catalyzed method for sulfur-containing 3-methyleneisoindolin-1-one derivatives, offering streamlined synthesis for reliable pharmaceutical intermediate suppliers.
Novel one-step carbonylation method offers mild conditions and high yields for 3,4-substituted coumarins, ensuring reliable supply chain stability.
Novel ruthenium-catalyzed route offers high-purity pharmaceutical intermediates with simplified supply chain and cost reduction capabilities.
Patent CN109761975B reveals a catalyst-free aminomethylation route for imidazoheteroaryls, offering significant cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN105085275A introduces a green ortho-nitration method. Enhance supply chain reliability and reduce purification costs with high-selectivity pharma intermediates.
Advanced Pd-catalyzed synthesis of ortho-deuterated benzoic acid derivatives. High selectivity, recyclable directing groups, and scalable manufacturing for pharmaceutical intermediates.
Patent CN109232529A reveals mild Rh(III) catalysis for nitrogen heterocycles. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel Pd-catalyzed C-H activation method for o-nitroacetophenone. Safe, eco-friendly route offering high regioselectivity for pharma intermediates.
Patent CN114956924B reveals a novel Pd-catalyzed method for polyfluorinated biarenes. Discover cost-effective supply chain solutions and high-purity manufacturing capabilities.
Patent CN108997193B reveals a cobalt-catalyzed C-H activation method for difluoroalkyl heterocycles, offering cost-effective synthesis for pharma and agrochemical applications.